Victoza launched in UK
July 9, 2009Sales and Marketing Victoza, diabetes
Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …
New clients for Cegedim Dendrite
July 9, 2009Medical Communications Cegedim
Cegedim Dendrite, a leading provider of CRM software and healthcare data to the pharma industry, has announced significant growth over …
Writing on the wall for ‘pay to delay’ generics deals
July 9, 2009Research and Development, Sales and Marketing FDA, US, generics
Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …
Genzyme’s woes are a boost for Shire and Protalix
July 9, 2009Research and Development, Sales and Marketing FDA, Genzyme, US
The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …
Europe launches pharma competition crackdown
July 8, 2009Research and Development Europe, generics
The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …
Eisai opens new European HQ in the UK
July 8, 2009Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ
Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …
UCB opens new UK biologics research centre
July 8, 2009Research and Development UCB
UCB has officially opened its new biologics research centre in the UK, representing an investment of £25 million for the …
GMP violations at Indian CMO hit UK generics makers
July 8, 2009Manufacturing and Production Asia, India
Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …
Sanofi moves to quell Lantus safety concerns
July 7, 2009Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes
Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …
Depression warnings for Chantix and Zyban
July 7, 2009Research and Development, Sales and Marketing Chantix, FDA, US, drug safety
Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …
PM Soc’s Digital Media Awards to highlight pioneering work
July 7, 2009Sales and Marketing digi, pm society
UK pharma companies and agencies are being invited to submit entries to the industry's first-ever digital media awards, which aim …
Vasella: on leadership
July 7, 2009Sales and Marketing Novartis, Vasella, leadership, management
Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …
Pharmaceutical manufacturing: news in brief
July 6, 2009Manufacturing and Production Genzyme, Quotient
Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …
NHS expectations ‘artificially inflated’
July 6, 2009NHS, healthcare
Expectations of what the NHS can deliver may be artificially inflated by the government's latest grand plan, according to the …
Novasep buys Henogen to get ‘bigger in bio’
July 6, 2009Manufacturing and Production Novasep
French contract manufacturing firm Novasep has acquired a Belgian company, Henogen, in order to expand the range of biologic drugs …
Roche’s ABPI exit – a deliberate snub?
July 3, 2009Research and Development, Sales and Marketing ABPI, Roche
By Nicola O’BrienRoche is yet to explain its controversial exit from the ABPI, but the company seems determined to make …
Euro RSCG buys Medicom
July 3, 2009Medical Communications Euro RSCG, advertising
Euro RSCG Life, one of healthcare's largest communications groups, has acquired the London-based Medicom Group. The medical communications agency is …
HRA Pharma opens UK subsidiary
July 3, 2009Sales and Marketing HRA Pharma
Privately-owned French drug maker HRA Pharma, which specialises in reproductive health and endocrinology, has opened its first UK subsidiary. The …
Asia Pacific vaccines market requires flexible, targeted portfolios
July 2, 2009Research and Development, Sales and Marketing Asia, vaccines
Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific …
Onglyza and Cimzia recommended by CHMP
July 2, 2009Research and Development, Sales and Marketing AZ, BMS, EMEA, Europe, Ongylza
Bristol-Myers Squibb andAstraZeneca's type II diabetes treatment Onglyza is among the brands to have received positive opinions from the Committee …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
